REGENTIS BIOMATERIALS LTD. (RGNT)
↓ Download CSVKey ratios (FY2025)
-287.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$6.97M | $932.0K | -$1.93M | — |
| Net Income | -$13.65M | $4.80M | -$4.13M | — |
| EPS (Diluted) | $-24.16 | $1.72 | $-24.09 | — |
| Total Assets | $7.62M | $482.0K | — | — |
| Total Liabilities | $2.87M | $6.49M | — | — |
| Shareholders' Equity | $4.74M | -$41.10M | -$45.91M | -$42.06M |
| Cash & Equivalents | $7.38M | — | — | — |
| Operating Cash Flow | -$1.38M | -$641.0K | -$1.22M | — |
| Shares Outstanding | 566.7K | 2.77M | 173.5K | — |